Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
| Code | Description | Unit |
|---|---|---|
| USP-1471619 | Norfloxacin Related Compound K - (6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid) | 15 mg |
| USP-1483436 | Oxiconazole Related Compound A - (2',4'-Dichloro-2-imidazol-1-ylacetophenone (E)-[O-(2,4-dichlorobenzyl)oxime]) | 20 mg |
| USP-1483447 | Oxiconazole Related Compound B - ((Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime) | 20 mg |
| USP-1533035 | Phenylephrine Related Compound D - ((R)-3-{2-[Benzyl(methyl)amino]-1-hydroxyethyl}phenol) | 30 mg |
| USP-1533046 | Phenylephrine Related Compound E - (2-[Benzyl(methyl)amino]-1-(3-hydroxyphenyl)ethan-1-one hydrochloride) | 30 mg |
| USP-1600868 | Repaglinide Related Compound E - ((R)-2-Ethoxy-4-[2-( {3-methyl-1-[2-(piperidin-1-yl)phenyl] butyl}amino)-2-oxoethyl] benzoic acid) | 20 mg |
| USP-1650028 | Tetracaine Related Compound C - (MethyI 4-(butylamino)benzoate) | 25 mg |
| USP-1667315 | Timolol Related Compound B - (3-(tert-Butylamino)-2-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-ol) | 20 mg |
| USP-1667369 | Timolol Related Compound D - (4-Morpholino-1,2,5-thiadiazol-3-ol) | 20 mg |
| USP-1667643 | Tigecycline (INTERNATIONAL COLD CHAIN SHIPMENT REQUIRED) | 300 mg |
| USP-128581 | This item has been discontinued - Fluticasone Propionate Related Compound J | 15 mg |
| USP-1000818 | Abiraterone Acetate | 200 mg |
| USP-1000829 | Abiraterone System Suitability Mixture | 20 mg |
| USP-1036937 | p-Anisaldehyde | 3 x 500 mg |
| USP-1056130 | Benzophenone (Diphenylmethanone) | 25 mg |
| USP-1062020 | Benzyl Disulfide | 200 mg |
| USP-1116774 | Chlorophyll A | 15 mg |
| USP-1164697 | Daunorubicinone - ((8S,10S)-8-Acetyl-6,8,10,11-tetrahydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) | 25 mg |
| USP-1193356 | Iscotrizinol | 200 mg |
| USP-1218050 | Diphenhydramine N-Oxide - (2-(benzhydryloxy)-N,N-dimethylethan-1-amineoxide hydrochloride) | 25 mg |
| USP-1225758 | Doxorubicinone - ((8S,10S)-6,8,10,11-Tetrahydroxy-8-(hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione) | 25 mg |
| USP-1269028 | Ezetimibe | 250 mg |
| USP-1269039 | Ezetimibe System Suitability Mixture | 20 mg |
| USP-1270231 | Trigonella Foenum-graecum Seed Dry Extract | 1 g |
| USP-1327319 | 4-Hydroxyisoleucine | 35 mg |
| USP-1356891 | Lauryl Alcohol | 125 mg |
| USP-1367647 | Linoleyl Alcohol | 5 x 30 mg |
| USP-1478185 | Oleyl Alcohol | 5 x 30 mg |
| USP-1478210 | Oligosaccharide System Suitability Mixture A | 20 mg |
| USP-1478221 | Oligosaccharide System Suitability Mixture B | 20 |
| USP-1544993 | Plastic Additive 8 (Dioctadecyl disulfide) | 100 mg |
| USP-1619185 | Spirulina | 2 x 100 mg |
| USP-1671468 | Tolterodine S-Enantiomer - ((S)-2-[3-(Diisopropylamin)-1-phenylpropyl]-4-methylphenol tartrate) | 15 mg |
| USP-1671479 | Tolterodine System Suitability Mixture | 15 mg |
| USP-1671480 | Tolterodine Tartrate | 200 mg |
| USP-1018527 | Amantadine Related Compound B - (N-(Adamantan-1-yl)acetamide) | 25 mg |
| USP-1078245 | Budesonide Related Compound E - (16aIpha,17 -[butylidenebis(oxy)]-11Beta,21-dihydroxypregna-1,4, 14-triene-3,20-dione) | 25 mg |
| USP-1078267 | Budesonide Related Compound G - (16alpha,17-[butylidenebis(oxy)]-11beta, 21-dihydroxypregna-4-ene-3,20-dione) | 25 mg |
| USP-1193378 | Iscotrizinol Related Compound B - (4-[(4-{[4-(tert-butylcarbamoyl)phenyl]amino}-6-[(4-{[(2-ethylhexyl)oxy]carbonyl}phenyl)amino]-1,3,5-triazin-2-yl)amino]benzoic acid) | 25 mg |
| USP-1193414 | Iscotrizinol Related Compound F - (Bis(2-ethylhexyl) 4,4'-({6-[(4-carbamoylphenyl)amino]-1,3,5-triazine-2,4-diyl}bis(azanediyl))dibenzoate) | 25 mg |
| USP-1218027 | Diphenhydramine Related Compound B - (3-(benzhydryloxy)propane-1,2-diol) | 20 mg |
| USP-1231841 | Econazole Related Compound B - (2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine nitrate) | 15 mg |
| USP-1285829 | Fluticasone Propionate Related Compound D - (S-methyl 6alpha, 9alpha-difluoro-11beta-hydroxy-16alpha-methyl-3-oxo-17alpha-propionyloxyandrosta-1,4-diene-17beta-carbothioate | 15 mg |
| USP-1356574 | This item has been discontinued - Ketoprofen Related Compound E - ((S)-methyl 2-(3-benzoylphenyl)propanoate) | 50 mg |
| USP-1370065 | Loperamide Related Compound F - ((1r,4s)-4-(4-Chlorophenyl)-1-[4-(dimethylamino)-4-oxo-3,3-diphenylbutyl]-4-hydroxypiperidine L-oxide) | 25 mg |
| USP-1411016 | Methimazole Related Compound A - (2,2-Dimethoxy-N-methylethanamine) | 3 x 50 mg |
| USP-1411038 | Methimazole Related Compound C - (1-Methyl-2-(methylthio)-1H-imidazole) | 3 x 50 mg |
| USP-1463326 | Nicotine Related Compound A - (1,2,3,6-tetrahydro-2,3'-bipyridine) | 20 mg |
| USP-1463337 | Nicotine Related Compound B - (3-(1-methyl-1H-pyrrol-2-yl)pyridine) | 20 mg |
| USP-1463359 | Nicotine Related Compound D - (3-(4,5-dihydro-3H-pyrrol-2-yl)pyridine fumarate) | 20 mg |
| USP-1463360 | Nicotine Related Compound E - ((1RS,2S)-1-methyl-2-(pyridin-3-yl)pyrrolidine 1-oxide oxalate) | 20 mg |
| USP-1463371 | Nicotine Related Compound F - (3-(pyrrolidin-2-yl)pyridine) | 20 mg |
| USP-1463382 | Nicotine Related Compound G - ((S)-3-(piperidin-2-yl)pyridine) | 20 mg |
| USP-1481044 | Oxacillin Related Compound C - (5-Methyl-3-phenylisoxazole-4-carboxylic acid) | 15 mg |
| USP-1533024 | Phenylephrine Related Compound C - (1-(3-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride) | 30 mg |
| USP-1570315 | Propafenone Related Compound A - (N-{2-Hydroxy-3-[2-(3-phenylpropanoyl)phenoxy]propyl}-N-propylformamide) | 20 mg |
| USP-1642020 | Sulindac Related Compound B - ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylsulfonyl)benzylidene]-1H-inden-3-yl}acetic acid) | 20 mg |
| USP-1659001 | Thimerosal Related Compound A - (2,2'-Disulfanediyldibenzoic acid) | 50 mg |
| USP-1667326 | Timolol Related Compound C - (N-(tert-Butyl)-2,3-bis(4-morpholino-l,2,5-thiadiazol-3-yloxy)propan-l-amine maleate) | 20 mg |
| USP-1667348 | Timolol Related Compound F - (3-Chloro-4-morpholino-1,2,5-thiadiazol) | 20 mg |
| USP-1667443 | Timolol Related Compound E - ((S,Z)-4-({1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-yl}oxy)-4-oxobut-2-enoic acid maleate salt (1:1)) | 20 mg |
| USP-1667665 | Tigecycline Related Compound B - ((4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride) | 25 mg |
| USP-1578612 | Protamine Sulfate | 2,85 mg |
| USP-1087847 | Candesartan Cilexetil Related Compound D (1-{[(Cyclohexyloxy)carbonyl]oxy}ethyl 3-({2'-(2-ethyl-2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl}methyl)-2-oxo-2,3-dihydro-1H-benzimidazole-4-carboxylate) | 10 mg |
| USP-1087869 | Candesartan Cilexetil Related Compound F (1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-{[2'-(2-ethyl-2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate) | 10 mg |
| USP-1157013 | Cyclophosphamide Related Compound A (bis(2-chloroethyl)amine hydrochloride) (International Restricted Sales Item) | 25 mg |
| USP-1545001 | Plastic Additive 9 (DidodecyI 3,3'-thiodipropionate) | 100 mg |
| USP-1545012 | Plastic Additive 10 (Dioctadecyl 3,3'-thiodipropionate) | 100 mg |
| USP-1545045 | Plastic Additive 13 (Erucamide) | 100 mg |
| USP-1609909 | Schisandra chinensis Fruit Dry Extract | 1 g |
| USP-1012799 | Aleuritic Acid | 50 mg |
| USP-1041992 | Desfluoro Aprepitant (5-{[(2R,3S)-2-{(R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-phenylmorpholino]methyl}-2H-1,2,4-triazol-3(4H)-one) | 15 mg |
| USP-1087472 | Calycosin (7-Hydroxy-3-(3-hydroxy-4-methoxyphenyl)-4H-chromen-4-one) | 50 mg |
| USP-1087814 | Candesartan Cilexetil Related Compound A (Ethyl 1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylate) | 10 mg |
| USP-1087825 | Candesartan Cilexetil Related Compound B (1-(Cyclohexyloxycarbonyloxy)ethyl 1-{[2'-(1H- tetrazol-5-yl)biphenyl-4-yl]methyl}-2-oxo-2,3-dihydrobenzimidazole-7-carboxylate) | 10mg |
| USP-1091028 | Capric Alcohol | 5 x 30 mg |
| USP-1200881 | Dihydrodaunorubicin Hydrochloride ((8S,10S)-10-[(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride) | 20 mg |
| USP-1329913 | 5-Hydroxy-L-tryptophan | 100 mg |
| USP-1613928 | Sodium D-Pantoate | 100 mg |
| USP-1642031 | Sulindac Related Compound C ((Z)-2-{5-fluoro-2-methyl-1-[4-(methylthio)benzylidene]-1H-inden-3-yl}acetic acid) | 20 mg |
| USP-1643962 | Teriparatide (cool shipment required) (COLD SHIPMENT REQUIRED) | 1 mg |
| USP-1011878 | Adrenalone Hydrochloride (3',4'-Dihydroxy-2-(methylamino)acetophenone hydrochloride) | 25 mg |
| USP-1018516 | Amantadine Related Compound A (1-Chloroadamantane) | 25 mg |
| USP-1087870 | Candesartan Cilexetil Related Compound G (1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-2-ethoxybenzimidazole-7-carboxylic acid) | 10 mg |
| USP-1478651 | Ononin | 50 mg |
| USP-1533261 | Phenylephrine Related Compound F ((R)-2-Methyl-1,2,3,4-tetrahydroisoquinoline-4,8-diol hydrochloride monohydrate) | 30 mg |
| USP-1533272 | Phenylephrine Related Compound G ((R)-N-(2-Hydroxy-2-(3-hydroxyphenyl)ethyl)-N-methylglycine) | 30 mg |
| USP-1609895 | Schisandrin | 15 mg |
| USP-1687017 | Trihexyphenidyl Related Compound A (1-Phenyl-3-(piperidin-1-yl)propan-1-one hydrochloride) | 20 mg |
| USP-1342059 | Insulin Glargine (COLD SHIPMENT REQUIRED) | 15 mg |
| USP-1064058 | 3-Benzyl-4-Heptanone | 5 x 0,5 mL |
| USP-1154650 | Allyl Cyclohexane Valerate | 3 x 0,5 mL |
| USP-1162626 | Alpha-Damascone | 3 x 0,5 mL |
| USP-1025715 | Aminolevulinic Acid Hydrochloride | 200 mg |
| USP-1025726 | Aminolevulinic Acid Related Compound A (25 mg) - (3,3'-(Pyrazine-2,5-diyl)dipropionic acid) | 25 mg |
| USP-1025737 | Aminolevulinic Acid Related Compound B (25 mg) - (Methyl 5-(1,3-dioxoisoindolin-2-yl)-4-oxopentanoate) | 25 mg |
| USP-1038025 | Antazoline Related Compound A (15 mg) - (N-(2-Aminoethyl)-2-[benzyl(phenyl)amino]acetamide) | 15 mg |
| USP-1042055 | Arabinose | 50 mg |
| USP-1044108 | Astragaloside IV (100 mg) - ((3beta,6alpha,9beta,16beta,20R,24S)-16,25-Dihydroxy-3-(beta-D-xylopyranosyloxy)-20,24-epoxy-9,19-cyclolanostan-6-yl beta-D-glucopyranoside) | 100 mg |
| USP-1044119 | Astragalus Root Dry Extract | 1 g |